1. Home
  2. VBNK vs ATAI Comparison

VBNK vs ATAI Comparison

Compare VBNK & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VersaBank

VBNK

VersaBank

HOLD

Current Price

$14.41

Market Cap

374.8M

Sector

Finance

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.32

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VBNK
ATAI
Founded
1980
2018
Country
Canada
Netherlands
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.8M
1.4B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
VBNK
ATAI
Price
$14.41
$4.32
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$13.00
$14.00
AVG Volume (30 Days)
48.3K
3.6M
Earning Date
12-10-2025
11-12-2025
Dividend Yield
0.50%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$85,792,576.00
$3,018,000.00
Revenue This Year
$36.55
$943.83
Revenue Next Year
$29.23
N/A
P/E Ratio
$22.58
N/A
Revenue Growth
7.44
811.78
52 Week Low
$8.51
$1.15
52 Week High
$16.43
$6.75

Technical Indicators

Market Signals
Indicator
VBNK
ATAI
Relative Strength Index (RSI) 83.84 49.78
Support Level $11.88 $4.25
Resistance Level $14.69 $4.54
Average True Range (ATR) 0.43 0.22
MACD 0.25 0.10
Stochastic Oscillator 90.53 71.36

Price Performance

Historical Comparison
VBNK
ATAI

About VBNK VersaBank

VersaBank is a Canadian Schedule I chartered bank with a difference. It has 3 operating segments: Digital Banking Canada, Digital Banking USA and DRTC. It's, cloud-based, business-to-business deposit and lending model provides valued-added solutions to Canadian financial intermediary partners, enabling them to focus on growing their own businesses faster and more profitably. It obtains all of its deposits and provides the majority of its loans and leases electronically, with deposit and lending solutions for financial intermediaries that allow them to excel in their core businesses. In addition, leveraging its internally developed IT security software and capabilities, Company established a wholly owned, subsidiary. Geographically located in Canada and USA.

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Share on Social Networks: